Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide
Avis Budget Group Inc. | NYSE: CAR | Insider Fraud! | Take Action!

News

OPINIONS

bernstein-downgrades-plains-all-american-to-market-perform-lowers-price-target-to-145
Bernstein Downgrades Plains All American t...
02/07/2023 12:07:38

Bernstein analyst Jean Ann downgrades Plains All American (NASDAQ:PAA) from Outperform to Market Perform and lowers the pric...

credit-suisse-maintains-outperform-on-cme-group-raises-price-target-to-198
Credit Suisse Maintains Outperform on CME ...
02/07/2023 12:07:09

Credit Suisse analyst Gautam Sawant maintains CME Group (NASDAQ:CME) with a Outperform and raises the price target from $192...

medicenna-therapeutics-q3-eps-0015-beats-007-estimate-cash-equivalents-of-362m
Medicenna Therapeutics Q3 EPS $(0.015) Bea...
02/07/2023 12:07:08

Medicenna Therapeutics (NASDAQ:MDNA) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate o...

catalent-reiterates-fy23-guidance-with-revenue-of-4625b-4875b-compared-to-consensus-of-508b-and-adjusted-ebitda-of-122b-13b
Catalent Reiterates FY23 Guidance, With Re...
02/07/2023 12:06:44

The company expects FY23 adjusted income of $567 million - $648 million.

pgti-announces-250m-share-repurchase-program
PGTI Announces $250M Share Repurchase Program
02/07/2023 12:05:46

ac-immune-awarded-new-grants-from-mjff-target-als-supporting-programs-targeting-tdp-43
AC Immune Awarded New Grants From MJFF, Ta...
02/07/2023 12:05:29

The Michael J. Fox Foundation grant supports the development of AC Immune's first-in-class TDP-43 PET tracer program ...

hamilton-lane-q3-gaap-eps-031-management-and-advisory-fees-up-22
Hamilton Lane Q3 GAAP EPS $0.31; Managemen...
02/07/2023 12:05:23

aldeyra-therapeutics-announces-fda-acceptance-of-new-drug-application-for-reproxalap-for-treatment-of-dry-eye-disease
Aldeyra Therapeutics Announces FDA Accepta...
02/07/2023 12:05:14

signa-sports-united-clocked-28-revenue-growth-in-q4-to-300m
SIGNA Sports United Clocked 28% Revenue Gr...
02/07/2023 12:05:11

rocket-pharmaceuticals-receives-fda-regenerative-medicine-advanced-therapy-designation-for-rp-a501-gene-therapy-for-danon-disease
Rocket Pharmaceuticals Receives FDA Regene...
02/07/2023 12:04:44

national-geographic-society-and-iridium-collaborate-to-support-research-and-exploration
National Geographic Society and Iridium Co...
02/07/2023 12:04:24

ares-capital-q4-eps-063-beats-056-estimate
Ares Capital Q4 EPS $0.63 Beats $0.56 Esti...
02/07/2023 12:04:09

Ares Capital (NASDAQ:ARCC) reported quarterly earnings of $0.63 per share which beat the analyst consensus estimate of $0.56 by...

lizhi-highlights-ai-powered-voice-technology
LIZHI Highlights AI-Powered Voice Technology
02/07/2023 12:04:05

incyte-q4-adjusted-eps-062-beats-058-estimate-sales-92670m-beat-88110m-estimate
Incyte Q4 Adjusted EPS $0.62 Beats $0.58 E...
02/07/2023 12:03:40

Incyte (NASDAQ:INCY) reported quarterly earnings of $0.62 per share which beat the analyst consensus estimate of $0.58 by 6.9 p...

fiserv-q4-adj-eps-191-beats-190-estimate-adj-sales-436b-beat-434b-estimate
Fiserv Q4 Adj. EPS $1.91 Beats $1.90 Estim...
02/07/2023 12:03:23

Fiserv (NASDAQ:FISV) reported quarterly earnings of $1.91 per share which beat the analyst consensus estimate of $1.90 by 0.53 ...

malibu-anticipates-fy23-net-sales-growth-in-the-mid-to-high-single-digits-percentage
Malibu Anticipates FY23 Net Sales Growth i...
02/07/2023 12:03:09

valvoline-sees-fy23-net-revenues-15b-15b-vs-144b-est
Valvoline Sees FY23 Net Revenues $1.5B-$1....
02/07/2023 12:03:00

barclays-maintains-overweight-on-post-hldgs-raises-price-target-to-105
Barclays Maintains Overweight on Post Hldg...
02/07/2023 12:02:45

Barclays analyst Andrew Lazar maintains Post Hldgs (NYSE:POST) with a Overweight and raises the price target from $102 to $105.

insiders-buying-ameriserv-financial-and-2-other-penny-stocks
Insiders Buying AmeriServ Financial And 2 ...
02/07/2023 12:02:19

The Dow Jones dropped by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or con...

akoustis-technologies-q2-adj-eps-019-beats-025-estimate-sales-587m-miss-592m-estimate
Akoustis Technologies Q2 Adj EPS $(0.19) B...
02/07/2023 12:02:18

Akoustis Technologies (NASDAQ:AKTS) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of...

Securely connect your financial account with CORE using Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

02/07/2023 Singularity Future Technology Ltd. (SGLY)
02/10/2023 Twist Bioscience Corporation (TWST)
02/13/2023 Iris Energy Limited (IREN)
02/14/2023 Sunlight Financial Holdings Inc. f/k/a Spartan Acquisition Corp. II (SUNL)
02/21/2023 Daktronics, Inc. (DAKT)
02/28/2023 Gaotu Techedu Inc. F/K/A Gsx Techedu Inc. (GOTU)
03/06/2023 Avaya Holdings Corp. (AVYA)
03/07/2023 Enovix Corporation (ENVX)
03/13/2023 Southwest Airlines Co. (LUV)
03/14/2023 International Business Machines Corporation (IBM)

NEW CASE INVESTIGATION

Iovance Biotherapeutics, Inc. (IOVA)
CORE Finalist